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Background: Allergic rhinitis is one of the commonest atopic diseases which contribute to significant morbidity
world wide while its epidemiology in Tanzania remains sparse. There was paucity of information regarding allergic
rhinitis in our setting; therefore it was important to conduct this study to describe our experience on allergic
rhinitis, associated co-morbidities and treatment outcome in patients attending Bugando Medical Centre.
Methods: This was descriptive cross-sectional study involving all patients with a clinical diagnosis of allergic rhinitis
at Bugando Medical Centre over a three-month period between June 2011 and August 2011. Data was collected
using a pre-tested coded questionnaire and analyzed using SPSS statistical computer software version 17.0.
Results: A total of 190 patients were studied giving the prevalence of allergic rhinitis 14.7%. The median age of the
patients was 8.5 years. The male to female ratio was 1:1. Adenoid hypertrophy, tonsillitis, hypertrophy of inferior
turbinate, nasal polyps, otitis media and sinusitis were the most common co-morbidities affecting 92.6% of cases
and were the major reason for attending hospital services. Sleep disturbance was common in children with
adenoids hypertrophy (χ2 = 28.691, P = 0.000). Allergic conjunctivitis was found in 51.9%. The most common
identified triggers were dust, strong perfume odors and cold weather (P < 0.05). Strong perfume odors affect female
than males (χ2 = 4.583, P = 0.032). In this study family history of allergic rhinitis was not a significant risk factor
(P =0.423). The majority of patients (68.8%) were treated surgically for allergic rhinitis co morbidities. Post operative
complication and mortality rates were 2.9% and 1.6% respectively. The overall median duration of hospital stay of
in-patients was 3 days (2 – 28 days). Most patients (98.4%) had satisfactory results at discharge.
Conclusion: The study shows that allergic rhinitis is common in our settings representing 14.7% of all
otorhinolaryngology and commonly affecting children and adolescent. Sufferers seek medical services due to
co-morbidities of which combination of surgical and medical treatment was needed. High index of suspicions in
diagnosing allergic rhinitis and early treatment is recommended.
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Allergic rhinitis is recognized as one of the most com-
mon otorhinolaryngological condition which has consid-
erable effects on quality of life and can have significant
consequences if left untreated [1]. Globally allergic rhin-
itis constitutes a worldwide public health problem with a
prevalence of 10% to 40% and the trend is increasing* Correspondence: drphillipoleo@yahoo.com
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reproduction in any medium, provided the or[2-5]. About 20 to 40 million people in the United States
alone are estimated to be affected, [6] with 3.5 million
lost workdays and 2 million lost schooldays annually [1].
Local population-based studies have reported a preva-
lence of allergic rhinitis of 44% in Singaporean school
children [7]. In UK intermittent allergic rhinitis (also
known as seasonal allergic rhinitis or hay fever affects up
to 30% of adults and 40% of children at some time in
their lives [8].
Allergic rhinitis is associated with significant co-
morbidities and health care costs [9] and has been. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mary care clinics [10]. The total burden of allergic rhin-
itis lies on impaired physical and social functioning and
also in a financial burden for treatment of its co-morbid
diseases [1]. Allergic rhinitis commonly causes sleep dis-
turbance, fatigue, listlessness irritability, and poor con-
centration leading to developmental delay, impaired
learning ability and poor school performance in children
[11-14]. Socially unacceptable behavior such as sniffing,
sneezing, noisy breathing and coughing may lead to iso-
lation and rejection at school and home. Further morbid-
ity results from associated conditions such as sinusitis,
adenoids, tonsil hypertrophy and otitis media [11].
Time trend studies of the prevalence of allergies in
Africa show a consistent increase over a period of
7–10 years [15]. In South African epidemiological data
are scarce but the overall prevalence of allergic rhinitis in
children is at least 20% to 24% and there is evidence of
increasing prevalence [11]. In Tanzania the data con-
cerning allergic rhinitis are limited. Observation from
Bugando Medical centre E.N.T clinical records reveals
that allergic rhinitis and its associated co morbidities are
common problem encountered with increasing trend for
the past three years. Despite adverse sequalae, allergic
rhinitis remains unrecognized and miss managed condi-
tion. Further more many patients do not recognize aller-
gic rhinitis as a disease and therefore do not consult a
physician [16].
The aim of this study was to describe our experience
on allergic rhinitis, associated co-morbidities and treat-
ment outcome among patient attending Bugando Med-
ical Centre. Early identification of patient with allergic
rhinitis and its co-morbidities would suggest develop-
ment of guideline for early detection and proper treat-
ment of allergic rhinitis and so reduce development of
co-morbidities.
Methods
Study design and setting
This was a descriptive prospective hospital-based study
of patients with clinical Allergic rhinitis carried out at
Bugando Medical Centre in Northwestern Tanzania over
a period of three months from July to September 2011.
Bugando Medical Centre is located in Mwanza city
along the shore of Lake Victoria in the northwestern
part of Tanzania. It is a tertiary care and teaching hos-
pital for the Catholic University of Health and Allied
Sciences- Bugando (CUHAS-Bugando) and other para-
medics and has a bed capacity of 1000. Bugando Medical
Centre is one of the four largest referral hospitals in the
country and serves as a referral centre for tertiary spe-
cialist care for a catchment population of approximately
13 million people from Mwanza, Mara, Kagera, Shinyanga,
Tabora and Kigoma regions.Study subjects and procedures
The study included all patients with clinical diagnosis of
allergic rhinitis presented with two or more recurrent
nasal symptoms of excessive sneezing, watery nasal dis-
charge, nasal congestion and itching of nose and eyes in
all age group and sex attended Bugando Medical Centre
ENT clinic and ENT wards during the study period.
Patients with co-morbid conditions associated with aller-
gic rhinitis like otitis media, nasal polyps, tonsillitis,
hypertrophied turbinate and sinusitis were also included
in the study. Patient who refused investigations i.e. nasal
scrapings and those received intranasal steroid one week
prior to the enrollment into the study were excluded
from the study. Recruitment of patient to participate in
the study was done at ENT clinics and wards. Patients
were screened for inclusion criteria and those who met
the inclusion criteria were given an explanation about
the study and requested to sign a written informed con-
sent for the study before being enrolled in the study. In
case of children below 18 years the Guardian/Parents
were asked to consent on their behalf. Convenient
sampling of patients who met the inclusion criteria was
performed until the sample size was reached.
Data were collected using a pre-tested coded question-
naire and physical examination. Data administered in the
questionnaire included; patients characteristics (e.g. age,
sex, occupation), nasal symptoms, eye symptoms, age
of onset of symptoms, triggering factors, presence or
absence of family history of allergic rhinitis and asthma
in the first and second degree relatives, presence of co
morbidity and the effects to the quality of life (defined as
interference with daily activities and sleep disturbances).
Appropriate examination was done to all patients where
candidate with nose complaints were examined using
anterior rhinoscopy. All candidates with ear complaints
were inspected using otoscope for evidence of eustachian
tube dysfunction and otitis media. Children who showed
features of allergic rhinitis and history of sleep noisy
snoring or apnoea their posterior oropharyngeal wall
were examined for adenoid hypertrophy with the aid of
wooden tongue spatula. Sinusitis in atopic patient was
defined by clinical presentation of facial pain, blocked
nose, thicker and purulent rhinorrhoea and or anosmia.
Paranasal sinus radiographs X - Ray submental vertical
(water) view was taken in all suspected respondents for
air/fluid level, septal deviation and thickening mucosa
and was interpreted by an experienced radiologist. Extra-
capsular tonsillectomy and adenoidectomies were done
in selected patients who had enlarged tonsils and adenoid
hypertrophy which obstruct breathing, causing snoring,
and sleep apnoea, difficult in feeding and recurrent
bacterial infection.
In selected patients with hypertrophy of inferior
turbinate with obstructive nasal symptoms electrical
Table 1 Distribution of patients according to age group
Age group (Years) Frequency Percentage
0 – 10 108 56.8
11 – 20 23 12.1
21 – 30 27 14.2
31 -40 15 7.9
41 – 50 11 5.8
51- 60 5 2.6
61+ 1 0.5
Total 190 100.0
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general anaesthesia was done. Patient with chronic max-
illary sinusitis were treated by Caldwell-luc procedure.
The research assistant and Principle Investigator
gathered relevant information regarding history and
physical examination and the Scrapings of secretions
and nasal mucosa cells [17] were taken from all patients
and eosinophils, neutrophils and basophils count was
done. Nasal Eosinophil infiltration is the cornerstone of
allergic inflammation [18] and was found to be sensitive
for the diagnosis of allergic rhinitis [19,20]. Nasal mucosal
specimens were scraped from the surfaces of the middle
thirds of inferior turbinate with specially made wooden
spatula as rhinoprobes. They transferred onto plain glass
slides, fixed in 95% ethyl alcohol for at least 1 minute,
excess alcohol was drained. The collected slides were
sent to the laboratory for staining. The slides were
dipped sequentially in modified Wright- Giemsa stain,
for 15 seconds, in Volu-Sol buffer for 30 seconds, and
in Volu-Sol hematology rinse for 5 seconds. The slides
were drained of excess fluid between the procedures.
After air drying, the slides were examined under oil
immersion by light microscopy [21,22]. At least 10-well
spread, high power epithelium fields were examined. It
was known from literature that nasal cytology assist in
(1) distinguishing inflammatory from non-inflammatory
rhinopathies; (2) distinguishing between allergic, non-
allergic, and infectious rhinitis; (3) distinguishing be-
tween viral and bacterial infections; (4) following the
course of a disease; and (5) following the response to
treatment.
The quantitative score of nasal eosinophils and meta-
chromatic cells were rated according to a scale previously
described by Meltzer [23]. The grading were semiquanti-
tative on a scale of 0 to 4 + [21]. It was shown that the
presence of either nasal eosinophilic or basophilic meta-
chromatic cell provides the best sensitivity and specificity
[20,24]. Eosinophil scores and/or basophilic metachrom-
atic cell scores of 1 was considered positive cut-off points
for the diagnosis of allergic rhinitis. The diagnosis of pa-
tient with allergic rhinitis and associated co-morbidities
was made clinically based on the validated questionnaire
derived from international studies of allergic rhinitis i.e.
Score For Allergic Rhinitis (SFAR) and International
Study of Asthma and Allergies in Childhood (ISAAC)
questionnaire where they had satisfactory sensitivity and
specificity, in the absence of any allergic test in develop-
ing countries [3]
All patients with no co morbidities were treated con-
servatively with intra nasal corticosteroids (Fluticasone)
and oral antihistamine citerizine and selected patients
with co morbidities were operated accordingly. Patients
were followed up until the day of discharge or death.
After discharge patients were followed up at our ENTclinic for one month (30 days) period. Length of hospital
stay (LOS) and mortality were recorded at the end of
study period.Statistical data analysis
Data was analyzed using SPSS software version 17.0 with
the guide of medical statistician. Data was summarized
in the form of proportions frequency tables, bar and pie
charts for categorical variables. Appropriate summary
was used for continuous variables such as Mean, median,
mode, standard deviation and histogram. Chi- square test
was used to test for significance of association between
predictors and outcome variables in the categorical
variable. Odds ratio was calculated to test the strength
of association between predictor and outcome variables
in the continuous variables. Significance was defined as a
p-value of less than 0.05. Multivariate logistic regression
analysis was used to determine the predictor variables
that are associated with outcome.Ethical consideration
Ethical approval to conduct the study was obtained from
the CUHAS-Bugando/BMC joint institutional ethic re-
view committee before the commencement of the study.
Informed consent was sought from each patient before
being enrolled into the study.Results
During the study period, a total of 1294 ENT patients
were seen at Bugando Medical Centre. Of these,
200 patients had a clinical diagnosis of Allergic rhinitis.
Ten patients were excluded from the study due to failure
to meet inclusion criteria. Thus, 190 patients were stud-
ied representing 14.7% of cases. There were 95 (50.0%)
males and 95 (50.0%) females with a male to female ratio
of 1:1. The age of the patients raged from 5 months to
56 years with a median age of 8.5 years. The model age
group was 0 –10 years accounting 55.8% of cases
(Table 1).
Table 3 Distribution of patients according to nasal and
eye symptoms
Symptoms Response Frequency Percentage
Nasal symptoms Blocked nose 144 75.8




Nasal itching 101 53.2
Eye symptoms Watery eyes 63 33.2




Cold weather 53 27.9
Perfume 34 17.9
Smoke 7 3.7
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school age group and occupation of the patients is as
shown in the Table 2.
The age of onset of allergic rhinitis symptoms ranged
from 2 months to 56 years with a median age of 3 years.
The onset of symptoms were significantly associated
with co-morbidities (χ2 = 10.963, P = 0.001).
The majority of patients, 189 (99.5%) presented with
nasal symptoms, of which blocked nose was the most
common presentation affecting 75.0% of patients (Table 3).
There was statistically significant association between the
blocked nose and age below 12 years in the study popula-
tion. (χ2 = 9.513, P = 0.002). Ninety-eight (51.6%) patients
had eye symptoms (rhinoconjuctivitis), of which watery
eye discharge was the most common symptoms affecting
33.2% of cases.
Most patients 112 (58.9%) were able to identify the
triggers of their allergic symptom and dust was reported
to be the most common triggering factor in 39.5% of
patients (Table 3). There was a significant association
between the dust allergens and sneezing in patient with
allergic rhinitis (χ2 = 12.391, P = 0.002), there was also
significant association between sex and strong perfume
odors (χ2 = 4.583, P = 0.032). Seventy-four (38.9%) patients
reported to have family history of allergic rhinitis.
In this study, associated sleep disturbance was
reported in 141 (74.2%) patients. There was a strong
statistical association between sleep disturbance and
presence of adenoid hypertrophy (χ2 = 28.691, P = 0.000)
but not with chronic tonsillitis (χ2 = 2.914, P = 0.088).
One hundred and seventy-seven (93.3%) patients ad-
mitted to have interference with their daily activities.
Majority of patients 179 (92.6%) had co-morbidities
associated with allergic rhinitis as shown in Table 4.Table 2 Distribution of patients according to education
and occupation
Variable Response Frequency Percentage
Level of education Pre school 77 40.5
Primary education 44 23.3
Secondary education 51 26.8
Tertiary education 18 9.5
Total 190 100




Mining workers 2 1.8
Industrial workers 2 1.8
Health workers 2 1.8
Total 113 100.0Patients who had allergic rhinitis with co-morbidities
had significant interference with quality of life (sleep dis-
turbance and work) compared to allergic rhinitis
patients without co-morbidities (χ2 = 20.711, P = 0.000),
and younger age at onset had significant association with
development of co-morbidities (χ2 = 76.040, P = 0.01).
X-ray was taken in 14 patients who had symptoms of
sinusitis. Out of these 5 (35.7%) were found to have
radiological features of chronic sinusitis. Nasal scrapings
were taken in all 190 patients. Neutrophils were found
in 177 (77.4%), esinophils 139 (73.2%) and there were
no cells found in 18 (9.47%) slides. Eosinophils were
higher in females (χ2 = 7.746, P = 0.005) and in patient
with family history of AR (χ2 = 5.309, P = 0.021).
One hundred and four (54.7%) patients were admitted
to hospital for surgical intervention resulting from co
morbidities associated with allergic rhinitis (Table 5).
Of these, tonsillectomy was the most frequent type of
surgical procedure performed accounting for 68.3% of
cases. The remaining 86 (45.3%) patients were treated by
non-surgical approach (conservatively).
The overall hospital stay for the admitted patients
ranged from 2 to 28 days with a mean of 4.6 ± 3.6 days.
The median was 3 days.Table 4 Distribution of patients according to their co
morbidities
Co morbidities Number of patients Percentage
Recurrent tonsillitis 105 55.3
Adenoid hypertrophy 88 46.3
Inferior turbinate hypertrophy 77 40.5
Nasal polyps 18 9.5
Ear discharge 16 8.4
Sinusitis 10 5.3
Table 5 Distribution of patients according to the type of
surgical procedure performed (N = 104)




Caldwell luc 3 2.9
Turbinectomy 3 2.9
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patients who had bleeding post-adenotonsillectomy.
Nine (4.7%) patients were discharged against medical
advice. Of these 5 (55.5%) patients were due to long hos-
pital stay before operation. Two (22%) patients were due
to financial constrains, and 2 (22%) patient were due to
unknown reason.
In this study 3 patients died giving mortality rate of
1.6%. All deaths were attributed to post operative and
anesthetic complications. Two (1.9%) patients died from
respiratory arrest post operative and one (0.9%) patient
died of cardiopulmonary arrest during recovery period.
Discussion
Allergic rhinitis represents a global healthy problem with
considerable prevalence especially in children [25]. The
majority of patients in this study were children which
is comparable with previous studies done else where
[26-29]. The reason for increased number of children
with allergic rhinitis to attend medical services in this
study may be due to the fact that allergic rhinits is asso-
ciated with severe and troublesome symptoms which are
exacerbated by recurrent viral infections making parents
to seek medical attention while majority of symptoms
of allergic rhinitis are ignored by adult patients.
In this study, no gender predilection was observed
which is in agreement with other studies [30], but at vari-
ant with other studies which reported female [29,31,32]
and male [33] predominance respectively.
The prevalence of allergic rhinitis is increasing in
developing countries [34] due to the introduction of
Western life style [35] and environmental factors [25]
and it differs among countries and even among regions
within the same country [20]. In industrial countries like
USA the allergic rhinitis is one among the well docu-
mented disease and high prevalence of allergic rhinitis
have been reported to be more than 40% [36]. In the
present study the point prevalence of allergic rhinitis at
Bugando Medical Centre was 14.7%. This prevalence is
comparable to 13.7%,13% found in Kinshasa [37] Nairobi
Kenya [30] respectively. Higher prevalence of allergic
rhinitis have been reported in African countries such as
29.6% in Nigeria [29] and more than 30% in Cape Town
South Africa [11]. Several theories for the increasingprevalence of allergic rhinitis are climatic factors, in-
creasing in winter and rainy seasons, dietary changes,
environmental factors including industrial pollution.
These factors may also influence the prevalence in our
study and therefore it is recommended that future stud-
ies should be done in different periods within a year to
determine the variations. The prevalence of allergic
rhinitis in our study may actually be underestimate as
majority of patients with this condition are treated in
the peripheral hospitals and only patients with severe
symptoms or associated co-morbidities present to ENT
surgeon. A better picture of the magnitude of Allergic
rhinitis in this region requires comprehensive data col-
lection including both hospital and population-based
study.
Clinically allergic rhinitis is defined as allergen induced
inflammation of the nasal membrane and surrounding
tissues that results in sneezing, rhinorrhoea, conjunctivitis,
nasal congestion, and pruritis of the nose, palate, throat
and ears [38]. Nasal obstruction is associated with sleep
disorders, which can have a profound effect on quality of
life, mental health, learning, behavior and attention [39].
Vast majority of respondents in this study had nasal
symptoms of which blocked nose was found in many
patients and it was found to be the most troublesome
symptom. The same observation was also reported in
other studies done else where [40,41]. The reason for the
nasal obstruction was due to the co-existence with
adenoid hypertrophy, nasal congestion, inferior turbinate
hypertrophy and nasal polyps in majority of our study
population. In this study blocked nose showed significant
association with adenoid hypertrophy in children.
In the present study, the high proportion of patients
had runny nose (rhinorrhoea) compared to other studies
found in literature [42]. The reason for increased pro-
portion of runny nose is the fact that runny nose is com-
mon in small children which is commonly associated
with viral and bacteria infection especially in under five
which were the majority in our study.
The rate of allergic conjunctivitis found in this study is
higher as compared to other studies [26,43] and major-
ities of patients had watery eye discharge as compared to
eye itching. Ocular symptoms were considered trivial ill-
ness by most of our patients and were not complained.
The reason for the high proportion of allergic conjunc-
tivitis could be due to dusty environment which causes
symptoms in majorities of our study population. The
high prevalence of rhinoconjunctivitis was also found in
majorities of the centers of Africa and raises number of
questions and non allergic factors are found to be re-
sponsible [44]. Further studies are needed to determine
the factors responsible for rhinoconjunctivitis.
In the present study it was shown that the allergic
rhinitis symptoms could begins as early as one month
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reported in Paris [45]. This could be due to differences
in environment between the two countries. The study
also shows that the early onset of symptoms of allergic
rhinitis is significantly associated with the development
of co-morbidities. This explains the needs for public
awareness and early medical intervention.
Various environmental factors were found to increase
the risk of allergic rhinitis especially in children. Pollu-
tion factors such as environmental tobacco smoke ex-
posure, moulds, road traffic pollution and dusts seem to
be important risk factors of allergic rhinitis [25]. In this
study exposure to dust, weather changes, strong perfume
order, and smoke were most common self reported trig-
gers for allergic rhinitis where dust reported by major-
ities of patients. This observation is in agreement with
other studies reported elsewhere [2,46].
The proportion of patients with self-reported allergy
to dust was 39.5% which is lower than reported in
Nigeria [29] and South Africa [11]. Seventy three percent
of respondents noted trouble symptoms inside their
houses. The reason for these findings could be due to the
plenty of dust in our immediate environment and house
dust which mainly consists of dust mite, moulds, insects
and animal dander may be the etiological trigger in the
study population. In this study dust was found to have
statistical significant association with sneezing. Sneezing
aims to expel mucus containing irritating allergens and
cleanse the nasal cavity.
It was found in the present study that 17.9% and
27.9% of patients were affected by strong perfume and
cold weather respectively. This rate is lower compared
to 31.1% and 32.4% respectively reported in the litera-
ture [47]. Female patients with allergic rhinitis showed
statistical significant association with strong perfume
odor. This might be due to the social habits of using
strong perfumes which is commonly in female compared
to males.
Many patients with allergic rhinitis had their first
degree relatives suffering from the disease. Similar find-
ings were reported in other studies [11,48,49]. Unlike in
other studies where family history was significant risk
factor for allergic rhinitis [11,45], in the current study
family history of allergic rhinitis did not reach statistical
significance. The reason for poor association could be
due to small sample as compared to the general popula-
tion. However family history of allergic rhinitis showed
statistical significant association with early onset nasal
symptoms, which leads to early development of co-
morbidities.
The quality of life is often impaired in patients with al-
lergic rhinitis, due to the classic symptoms of the disease
(sneezing, pruritis, rhinorrhoea and nasal obstruction).
In addition, the pathophysiology of allergic rhinitis oftendisrupt sleep, leading to fatigue, daytime sleepiness,
irritability and memory deficit [39]. Sleep disturbance
was reported in most of our study population. Similar
observation was also reported from other studies [50].
While 74.2% of our patient had their sleep affected,
Machimu at al [51] reported sleep disturbance in 76.6%
of the study population. Nasal obstruction and nasal
congestion were responsible for the sleep disturbances.
In this study nasal obstruction and congestion cause
day time sleepiness in more than 70% of respondents
especially those who had sleep disturbance during night
time. This is in agreement with previous study [52]. The
reason for the nasal obstruction was adenoid hyper-
trophy in one hand and hypertrophy of inferior turbinate
in another hand. Adenoid hypertrophy was complained
in majority of patients and it was significantly associated
with sleep disturbance in children. Another cause of
nasal obstruction was rhinorrhoea triggered by allergens.
Most of our patients 93.3% reported to have interfer-
ence with their daily activities such as playing, working
etc. and thus they have impaired social life. This is in
agreement with other studies found in literature [53,54]
and it is higher than that reported by Bousquet [55].
The reason for the interference with daily activities is
probably due to severe symptoms of nasal blockage and
rhinorrhoea which also causes embarrassment to patients.
Besides its direct effect on the quality of life, allergic
rhinitis has significant co-morbid disorders such as
asthma, sinusitis, otitis media, conjunctivitis and adenoid
hypertrophy [25]. In the present study, more than 90%
of patients had associated co-morbidities which is con-
trary with other studies [34]. Many other studies reported
low incidence of associated co-morbidities. We could not
find the reason for these differences, this call for further
studies to explain these differences.
Multidisciplinary approach is needed in the treatment
of allergic rhinitis and its co-morbidities involving
paediatricians, allergists and the otolaryngologists [25].
Allergen avoidance require aggressive environmental
control which is effective but often practically difficult
[56]. Intranasal steroids are the treatment of choice and
are more effective than antihistamines for relief of nasal
obstruction however surgical therapy is reserved for co-
morbidities refractory to medical treatment. Immuno-
therapy may also be used [57].
With regard to treatment patterns, majority of patients
(54.7%) in this study underwent surgical treatment
which is at variant with findings from other studies [11]
where majority of allergic rhinitis patient were treated
conservatively and surgical management was reserved for
minority of cases who were refractory to medical treat-
ment. The most common indications for surgical treat-
ment in the present study were adenoid hypertrophy,
recurrent tonsillitis, nasal obstruction due to hypertrophy
Said et al. BMC Ear, Nose and Throat Disorders 2012, 12:13 Page 7 of 9
http://www.biomedcentral.com/1472-6815/12/13of inferior turbinate, nasal polyps and sinusitis. The high
rate of surgical treatment found in this study is attributed
to high proportion of patients with associated co-
morbidities requiring surgical interventions
In agreement with previous report [58], conservative
treatment in this study was done using mono therapy
with steroid nasal spray fluticasone which does not re-
sult in complete relief of symptoms and so prolongs the
hospital visit and affect compliance with long term use.
Allergen exposure in atopic individual activates mast
cells resulting in the release of mediators and cytokines
capable of inducing inflammatory cell recruitment in-
cluding eosinophils, neutrophils and basophils at the tar-
get organ level. Eosinophils in the nasal smear has shown
to display the best correlation with clinical allergic
rhinitis [59], and can be used not only to establishes the
diagnosis of allergic rhinitis but also useful in the follow
up of patients with this condition [22]. In this study oesi-
nophils were found in 73.2% of patients and were signifi-
cantly associated with female sex and family history of
allergic rhinitis. The reason for this association was not
known
Polymorpho-nuclear cells were found in 77.4% of our
patients. Since the presence of neutrophils provides evi-
dence substantiating the diagnosis of nasal infections,
high rate of nasal neutrophils in this study indicate that
nasal infections is common in these groups.
Nasal smears for oesinophils, basophils and neutro-
phils were negative in 9.7% of the slides. Unlike observa-
tion from other studies that nasal mucosa scrapings in
allergic rhinitis patients had large numbers of basophilic
metachromatic cells [60] in this studies no basophils was
found. The reason could be due to the fact that basophil
cells are found predominately in the nasal mucosa [23],
where proper nasal curettes (rhino-probe) are required
for acquisition of a large number of intact cells to inter-
pret. In contrary neutrophils and oesinophils are present
in both nasal secretion and within the nasal mucosa.
The overall average length of hospital stay for in
patients was 4.6 days. However for the patient under-
went adenotonsillectomy the average hospital stay was
3 days. This was in contrary with other studies done in
Malaysia where adenotonsillectomy was done safely as
day care surgery [46].
While gender was not found to be a risk factor,
younger age group was significantly associated with
increased length of hospital stay post adenotonsillect-
omy. Same observation was also reported in the literature
[61]. This is contrary with other studies [62]. The reason
for increased length of hospital stay was mostly due to
delay in conduction of the procedure, where patients
stayed in the ward for days awaiting surgery.
Patients who had chronic sinusitis were found to have
statistical significant association with increased length ofhospital stay. The reason for this is that during post
operative period, most of patients had associated oedema
and prolonged catheter placed for sinus drainage.
In the present study post operative bleeding was the
most post surgical complication. This is consistent with
other study [63]. The rate of post operative bleeding of
2.88% in the present study was in agreement to the rate
of 2.4% found in other studies [64]. The low rate of post
tonsillectomy bleeding was attributed to the suture tie
techniques used to arrest bleeding during tonsillectomy
at Bugando Medical Centre and also weekly follow up
post surgery was found to be effective in early detection
of delayed and episodic bleeding which can be corrected
before the development of life-threatening anaemia.
Majority of patients were discharged against medical
advice in the current study was caused by long hospital
stay especially before surgery. This is attributed to inad-
equate operating days for ENT patients despite of high
number of patients demanding surgical services. Further
more lack of essential surgical equipments such as
oxygen, gauze and surgical gowns during the study
period led to delay of surgical procedures.
AR is not common to cause death but it may occur
from its co-morbid conditions as 1.5% mortality rate
reported in a study done in Sweden [65] or as a result of
surgical complications. In the current study death rate
post adenotonsillectomy was 1.6%. High mortality rate
was previously reported [66] although there was no post-
operative deaths reported in study done in Germany [67].
In our study death occurred within the first 24 hours
post adenotonsillectomy in younger children who had
severe obstructive symptoms. Aspiration and respiratory
arrest may probably be the cause of death. This calls for
improvement of pediatric post operative care.
There was no death caused by bleeding in this study.
The reason was careful inspection of the nasopharynx
before performing surgery and curettage in a piecemeal
fashion under visual control which was done during
each adenoidectomy in order to prevent direct injury to
aberrant arteries.
The potential limitations of this study include the
absence of allergy testing, short study period, presence of
neutrophils in the nose and failure of estimating the
measure of quality of life based on a standardized and
validated (generic or disease-related) questionnaires. How-
ever, despite these limitations, the study has provided local
data that can help health care workers develop guideline
for early detection and proper treatment of allergic
rhinitis and so reduce development of co-morbidities.
Conclusion
Allergic rhinitis is common condition which is under
diagnosed in patients attending otorhinolaryngology de-
partment at Bugando Medical Centre and accounts for
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rhinitis causes considerable morbidities especially in
children. Many of the allergic rhinitis triggers are com-
monly found in our environment and houses. It is there-
fore recommended that:
 High index of suspicion and improvement of
laboratory diagnostic facilities for allergic rhinits are
needed in order elevate the prevalence of this
disease.
 Early detection and treatment of allergic rhinitis in
children is needed to improve healthy of the
sufferers
 Avoidance of allergic rhinitis trigger is the best first
line of management of allergic rhinits and so all
patients should be given education on avoidance of
the triggering factors.
 Further study on incidence and risk factors of
allergic rhinitis at Bugando Medical Centre ENT
patients is highly recommended.
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